Jonathan Poole
2016 - Genocea Biosciences
In 2016, Jonathan Poole earned a total compensation of $741.3K as Chief Financial Officer at Genocea Biosciences, a 31% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $110,300 |
|---|---|
| Option Awards | $257,000 |
| Salary | $367,433 |
| Other | $6,583 |
| Total | $741,316 |
Poole received $367.4K in salary, accounting for 50% of the total pay in 2016.
Poole also received $110.3K in non-equity incentive plan, $257K in option awards and $6.6K in other compensation.
Rankings
In 2016, Jonathan Poole's compensation ranked 9,631st out of 14,075 executives tracked by ExecPay. In other words, Poole earned more than 31.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,631 out of 14,075 | 32nd |
Division Manufacturing | 3,731 out of 5,486 | 32nd |
Major group Chemicals And Allied Products | 1,296 out of 1,900 | 32nd |
Industry group Drugs | 1,030 out of 1,543 | 33rd |
Industry Biological Products, Except Diagnostic Substances | 180 out of 287 | 37th |
Source: SEC filing on April 21, 2017.
Poole's colleagues
We found two more compensation records of executives who worked with Jonathan Poole at Genocea Biosciences in 2016.